These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response. Parodi B; Sanna A; Cedola A; Uccelli A; Kerlero de Rosbo N Front Immunol; 2021; 12():655212. PubMed ID: 34084164 [TBL] [Abstract][Full Text] [Related]
3. The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation. Wannick M; Assmann JC; Vielhauer JF; Offermanns S; Zillikens D; Sadik CD; Schwaninger M Front Immunol; 2018; 9():1890. PubMed ID: 30154797 [TBL] [Abstract][Full Text] [Related]
4. Dimethyl fumarate downregulates the immune response through the HCA von Glehn F; Dias-Carneiro RPC; Moraes AS; Farias AS; Silva VAPG; Oliveira FTM; Silva CEBG; de Carvalho F; Rahal E; Baecher-Allan C; Santos LMB Mult Scler Relat Disord; 2018 Jul; 23():46-50. PubMed ID: 29763776 [TBL] [Abstract][Full Text] [Related]
5. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Parodi B; Rossi S; Morando S; Cordano C; Bragoni A; Motta C; Usai C; Wipke BT; Scannevin RH; Mancardi GL; Centonze D; Kerlero de Rosbo N; Uccelli A Acta Neuropathol; 2015 Aug; 130(2):279-95. PubMed ID: 25920452 [TBL] [Abstract][Full Text] [Related]
6. Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells. Haarmann A; Nehen M; Deiß A; Buttmann M Int J Mol Sci; 2015 Aug; 16(8):19086-95. PubMed ID: 26287168 [TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis. Bevilacqua Rolfsen Ferreira da Silva G; Pereira das Neves S; Roque Oliveira SC; Marques F; Gomes de Oliveira A; de Lima Leite F; Cerqueira JJ J Autoimmun; 2022 Oct; 132():102893. PubMed ID: 36029715 [TBL] [Abstract][Full Text] [Related]
10. Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis. Lima ADR; Ferrari BB; Pradella F; Carvalho RM; Rivero SLS; Quintiliano RPS; Souza MA; Brunetti NS; Marques AM; Santos IP; Farias AS; Oliveira EC; Santos LMB Front Immunol; 2024; 15():1391949. PubMed ID: 38765015 [TBL] [Abstract][Full Text] [Related]
11. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis. Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542 [TBL] [Abstract][Full Text] [Related]
12. Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells. Fiedler SE; Kerns AR; Tsang C; Tsang V; Bourdette D; Salinthone S Biochem Biophys Res Commun; 2016 Jun; 475(1):19-24. PubMed ID: 27157139 [TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases. Majkutewicz I Eur J Pharmacol; 2022 Jul; 926():175025. PubMed ID: 35569547 [TBL] [Abstract][Full Text] [Related]
15. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis. de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368 [TBL] [Abstract][Full Text] [Related]
16. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils. Eberle M; Ebel P; Mayer CA; Barthelmes J; Tafferner N; Ferreiros N; Ulshöfer T; Henke M; Foerch C; de Bazo AM; Grösch S; Geisslinger G; Willecke K; Schiffmann S Immunol Cell Biol; 2015 Oct; 93(9):825-36. PubMed ID: 25833068 [TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Schulze-Topphoff U; Varrin-Doyer M; Pekarek K; Spencer CM; Shetty A; Sagan SA; Cree BA; Sobel RA; Wipke BT; Steinman L; Scannevin RH; Zamvil SS Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4777-82. PubMed ID: 27078105 [TBL] [Abstract][Full Text] [Related]
18. Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation. Offermanns S; Schwaninger M Trends Mol Med; 2015 Apr; 21(4):245-55. PubMed ID: 25766751 [TBL] [Abstract][Full Text] [Related]
19. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. Gopal S; Mikulskis A; Gold R; Fox RJ; Dawson KT; Amaravadi L Mult Scler; 2017 Dec; 23(14):1875-1883. PubMed ID: 28156185 [TBL] [Abstract][Full Text] [Related]
20. Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression. Rubant SA; Ludwig RJ; Diehl S; Hardt K; Kaufmann R; Pfeilschifter JM; Boehncke WH J Invest Dermatol; 2008 Feb; 128(2):326-31. PubMed ID: 17671516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]